Predictive Value of C-Reactive Protein for Infectious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Single-Center Prospective Study
- PMID: 39134911
- DOI: 10.1245/s10434-024-15986-3
Predictive Value of C-Reactive Protein for Infectious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Single-Center Prospective Study
Abstract
Background: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can be associated with significant morbidity and prolonged hospital stay. Postoperative infections account for a high burden of these complications. This study aimed to assess the predictive value of postoperative C-reactive protein (CRP) levels for overall infectious complications and anastomotic leaks.
Methods: This was a single-center prospective study of patients undergoing CRS and HIPEC for peritoneal metastases between 2018 and 2020 at Maisonneuve-Rosemont Hospital in Montreal, QC, Canada. CRP levels were measured daily for 10 days following surgery. A comparison was made between patients with infectious complications and those without.
Results: Ninety-nine patients were included. Thirty patients had infectious complications (30.3%) and four patients presented an anastomotic leak (4%). CRP levels were significantly higher in patients with infectious complications from postoperative days (PODs) 2-10. Daily cut-off values most accurately predicted infectious complications on day 8 (94.3 mg/L; area under the curve [AUC] 0.85, sensitivity [SE] 76.2%, specificity [SP] 94.7%, positive predictive value [PPV] 88.9%, negative predictive value [NPV] 87.8%; p < 0.0001) and day 9 (72.7 mg/L; AUC 0.89, SE 95.2%, SP 81.8%, PPV 76.9%, NPV 96.4%; p < 0.0001). Patients with infectious complications had longer operative time, higher peritoneal cancer index, and a higher number of intestinal anastomoses, while their baseline characteristics were comparable.
Conclusion: Measurement of CRP helps predict infectious complications following CRS and HIPEC, particularly on PODs 8 and 9. Cut-off values are more accurate after the first postoperative week, especially in ruling out infectious complications.
Keywords: C-reactive protein; CRP; CRS; Cytoreductive surgery; HIPEC; Hyperthermic intraperitoneal chemotherapy.
© 2024. Society of Surgical Oncology.
Similar articles
-
Anastomotic leakage following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: A clinical cohort study.Surg Oncol. 2024 Jun;54:102080. doi: 10.1016/j.suronc.2024.102080. Epub 2024 Apr 16. Surg Oncol. 2024. PMID: 38663060
-
A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.Ann Surg Oncol. 2016 May;23(5):1609-17. doi: 10.1245/s10434-015-5012-3. Epub 2015 Dec 17. Ann Surg Oncol. 2016. PMID: 26678406 Free PMC article. Clinical Trial.
-
Inflammatory biomarkers to predict postoperative infectious complications after cytoreductive surgery and HIPEC for peritoneal carcinomatosis.Eur J Surg Oncol. 2022 Feb;48(2):455-461. doi: 10.1016/j.ejso.2021.09.015. Epub 2021 Sep 21. Eur J Surg Oncol. 2022. PMID: 34565632
-
Diagnostic Value of C-Reactive Protein Levels in Postoperative Infectious Complications After Bariatric Surgery: a Systematic Review and Meta-Analysis.Obes Surg. 2019 Jul;29(7):2022-2029. doi: 10.1007/s11695-019-03832-5. Obes Surg. 2019. PMID: 30895509
-
Effect of hyperthermic intraperitoneal chemotherapy in combination with cytoreductive surgery on the prognosis of patients with colorectal cancer peritoneal metastasis: a systematic review and meta-analysis.World J Surg Oncol. 2022 Jun 14;20(1):200. doi: 10.1186/s12957-022-02666-3. World J Surg Oncol. 2022. PMID: 35701802 Free PMC article.
Cited by
-
Invited Editorial About the Clinical Significance of "Predictive Value of C-Reactive Protein for Infectious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Single-Center Prospective Study" by Charbonneau et al. : Postoperative CRP to Predict Postoperative Complications: A Myth or Reality?Ann Surg Oncol. 2024 Dec;31(13):8488-8490. doi: 10.1245/s10434-024-16339-w. Epub 2024 Oct 7. Ann Surg Oncol. 2024. PMID: 39375261 No abstract available.
References
-
- Deraco M, Santoro N, Carraro O, et al. Peritoneal carcinomatosis: feature of dissemination. A review. Tumori. 1999;85(1):1–5. https://doi.org/10.1177/030089169908500101 . - DOI - PubMed
-
- Baratti D, Kusamura S, Mingrone E, Balestra MR, Laterza B, Deraco M. Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2012;256(2):334–41. https://doi.org/10.1097/SLA.0b013e31825704e3 . - DOI - PubMed
-
- van Stein RM, Aalbers AGJ, Sonke GS, van Driel WJ. Hyperthermic intraperitoneal chemotherapy for ovarian and colorectal cancer: a review. JAMA Oncol. 2021;7(8):1231–8. https://doi.org/10.1001/jamaoncol.2021.0580 . - DOI - PubMed
-
- The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. Annals of surgical oncology. 2020;27(6):1753-1760. https://doi.org/10.1245/s10434-020-08316-w
-
- Quénet F, Elias D, Roca L, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256–66. https://doi.org/10.1016/s1470-2045(20)30599-4 . - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous